Cresco Labs (CRLBF) Change in Cash (2019 - 2025)
Cresco Labs (CRLBF) posted Change in Cash of $12.4 million for Q4 2025, up 117.42% on a QoQ basis from -$71.1 million in Q3 2025, and up 179.6% year-over-year from $4.4 million in Q4 2024.
Cresco Labs (CRLBF) Change in Cash (2019 - 2025) Analysis & Trends
Cresco Labs' Change in Cash history runs 7 years deep, the most recent figure standing at $12.4 million for Q4 2025.
- Quarterly Change in Cash rose 179.6% year-over-year to $12.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$33.6 million (down 157.22% YoY) and the FY2025 annual result came in at -$49.9 million, down 239.7% from the prior year.
- Change in Cash was $12.4 million for Q4 2025 at Cresco Labs, up from -$71.1 million in the prior quarter.
- Across five years, Change in Cash topped out at $118.2 million in Q1 2021 and bottomed at -$123.7 million in Q2 2021.
- A 5-year average of $973625.3 and a median of $3.9 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2021 — Change in Cash surged 827.67% — and 2025, when it sank 274.99%.
- Cresco Labs' Change in Cash stood at $28.7 million in 2021, then slumped by 137.67% to -$10.8 million in 2022, then surged by 58.41% to -$4.5 million in 2023, then plunged by 245.91% to -$15.6 million in 2024, then jumped by 179.6% to $12.4 million in 2025.
- Business Quant data shows CRLBF's Change in Cash at $12.4 million in Q4 2025, -$71.1 million in Q3 2025, and -$15.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 12.38 Mn |
| Sep 30, 2025 | -71.06 Mn |
| Dec 31, 2024 | -15.55 Mn |
| Sep 30, 2024 | 40.61 Mn |
| Dec 31, 2023 | -4.50 Mn |
| Sep 30, 2023 | 38.21 Mn |
| Dec 31, 2022 | -10.81 Mn |
| Sep 30, 2022 | 39.99 Mn |
| Jun 30, 2022 | -89.59 Mn |
| Mar 31, 2022 | -44.18 Mn |
| Dec 31, 2021 | 28.70 Mn |
| Sep 30, 2021 | 94.98 Mn |
| Jun 30, 2021 | -123.74 Mn |
| Mar 31, 2021 | 118.20 Mn |
| Dec 31, 2020 | 81.16 Mn |
| Sep 30, 2020 | -13.05 Mn |
| Mar 31, 2020 | 17.02 Mn |
| Dec 31, 2019 | -27.60 Mn |